SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001193125-23-180542
Filing Date
2023-06-30
Accepted
2023-06-30 16:56:36
Documents
8
Effectiveness Date
2023-06-30

Document Format Files

Seq Description Document Type Size
1 S-8 d491537ds8.htm S-8 35027
2 EX-5.1 d491537dex51.htm EX-5.1 7495
3 EX-23.1 d491537dex231.htm EX-23.1 1576
4 EX-23.2 d491537dex232.htm EX-23.2 1452
5 EX-99.2 d491537dex992.htm EX-99.2 7079
6 EX-FILING FEES d491537dexfilingfees.htm EX-FILING FEES 22318
7 GRAPHIC g491537g43s41.jpg GRAPHIC 3591
8 GRAPHIC g491537s2.jpg GRAPHIC 3249
  Complete submission text file 0001193125-23-180542.txt   85638
Mailing Address 444 WEST LAKE STREET, SUITE 1700 CHICAGO IL 60606
Business Address 444 WEST LAKE STREET, SUITE 1700 CHICAGO IL 60606 312-416-8592
MAIA Biotechnology, Inc. (Filer) CIK: 0001878313 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-273086 | Film No.: 231062504
SIC: 2834 Pharmaceutical Preparations